1. Predicting drug-induced liver injury in vitro by combining human 3D liver models and organ-on-chip technology. (September 2021) Authors: Cox, B; Barton, P.; Class, R.; Delatour, C.; Dell'Aiera, S.; Gillent, E.; Henshall, J; King, L. Journal: Toxicology letters Issue: Volume 350(2021)Supplement Page Start: S123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Modeling of COMPASS tokamak divertor liquid metal experiments. (December 2020) Authors: Horacek, J.; Dejarnac, R.; Cecrdle, J.; Tskhakaya, D.; Vertkov, A.; Cavalier, J.; Vondracek, P.; Jerab, M.; Barton, P.; van Oost, G.; Hron, M.; Weinzettl, V.; Sestak, D.; Lukes, S.; Adamek, J.; Prishvitsin, A.; Iafratti, M.; Gasparyan, Y.; Vasina, Y.; Naydenkova, D. Journal: Nuclear materials and energy Issue: Volume 25(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LIBS analysis of samples from the COMPASS vacuum chamber after liquid metal experiments – Li campaign. (December 2020) Authors: Veis, P.; Atikkuke, S.; Marin Roldan, A.; Dwivedi, V.; Veis, M.; Barton, P.; Jerab, M.; Dejarnac, R. Journal: Nuclear materials and energy Issue: Volume 25(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Overview of power exhaust experiments in the COMPASS divertor with liquid metals. (December 2020) Authors: Dejarnac, R.; Horacek, J.; Hron, M.; Jerab, M.; Adamek, J.; Atikukke, S.; Barton, P.; Cavalier, J.; Cecrdle, J.; Dimitrova, M.; Gauthier, E.; Iafrati, M.; Imrisek, M.; Marin Roldan, A.; Mazzitelli, G.; Naydenkova, D.; Prishvitcyn, A.; Tomes, M.; Tskhakaya, D.; Van Oost, G. Journal: Nuclear materials and energy Issue: Volume 25(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CHROMOSOMAL MAPPING OF HUMAN GLOBIN GENES. (April 1981) Authors: Barg, R.; Barton, P.; Ferguson-Smith, M. A.; Malcolm, S. Journal: Biochemical Society transactions Issue: Volume 9:Number 2(1981) Page Start: 124P Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hepatic drug transporters: the journey so far. (1st February 2016) Authors: Riley, R. J.; Foley, S. A.; Barton, P.; Soars, M. G.; Williamson, B. Journal: Expert opinion on drug metabolism and toxicology Issue: Volume 12:Number 2(2016:Feb.) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Preclinical comparison of the blood brain barrier (BBB) permeability of osimertinib (AZD9291) with other irreversible next generation EGFR TKIs. (December 2016) Authors: Colclough, N.; Ballard, P.G.; Barton, P.; Chen, K.; Cross, D.A.E.; Finlay, M.R.V.; Han, L.; Janefeldt, A.; Johnström, P.; Ward, R.A.; Wrigley, G.L.; Yan, Y.; Yates, J.W.T.; Zhang, D.; Zhang, Z. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗